Cup Revisions Through Anterior or Posterolateral Approach: an RCT
Launched by REINIER HAGA ORTHOPEDISCH CENTRUM · Aug 18, 2022
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18
- • On waiting list or scheduled for isolated cup revision surgery through anterior or posterolateral approach
- • A good command of the Dutch language
- Exclusion Criteria:
- • Revision for confirmed or suspected infection
- • Not suitable for both approaches under study, as judged by orthopaedic surgeon
- • Unable to fully understand study information and to accurately/reliably complete the questionnaires, as judged by researcher and/or orthopaedic surgeon
- • Unable to accurately follow instructions for study procedures / measurements, as judged by researcher and/or orthopaedic surgeon
- • Unwilling to sign informed consent form
About Reinier Haga Orthopedisch Centrum
Reinier Haga Orthopedisch Centrum is a leading orthopedic center dedicated to advancing musculoskeletal care through innovative clinical trials and research. Committed to improving patient outcomes, the center specializes in a wide range of orthopedic conditions and employs a multidisciplinary approach to treatment. With a focus on evidence-based practices, the Reinier Haga Orthopedisch Centrum collaborates with healthcare professionals and researchers to develop and evaluate new therapies, ultimately enhancing the quality of care provided to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zoetermeer, , Netherlands
Patients applied
Trial Officials
M. Rutgers, MD
Principal Investigator
Reinier Haga Orthopedisch Centrum
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials